Velo3D Announces First Quarter 2026 Financial Results
-
Revenue of
$13.8 million , up 48% year-over-year - Gross margin of 17.2%
-
Reaffirms outlook for 2026 revenue between
$60 million and$70 million and to turn EBITDA positive in the second half of 2026
Recent Business Developments
- Awarded a
$9.8 million , five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract supporting theDefense Logistics Agency's (DLA) Joint Additive Manufacturing Acceptability (JAMA) Pilot Parts Program, an initiative aimed at accelerating adoption of additively manufactured components acrossDepartment of War sustainment operations. - Appointed Jim Suva as Chief Financial Officer.
- Closed a firm commitment underwritten registered direct offering in
April 2026 of 3,571,428 shares of common stock, with gross proceeds of approximately$50 million .
"For the first quarter, we delivered a strong start to 2026 with revenue up 48% year‑over‑year, reflecting recent sales momentum and disciplined execution across our end markets," said
"Demand remains particularly strong in defense and aerospace, where customers are prioritizing scalable, high‑performance additive manufacturing solutions. To support this demand and accelerate our expansion, we completed a successful equity offering in April, securing additional capital to invest in talent and operational infrastructure. We believe our competitive position is strengthening as we deepen customer relationships and expand into new programs. We remain focused on executing our expansion plans to capture these opportunities and drive long‑term value creation."
|
($ in Millions, except percentages and per-share data) |
1st Quarter 2026 |
1st Quarter 2025 |
|
GAAP revenue |
|
|
|
GAAP gross margin |
17.2 % |
7.5 % |
|
GAAP net loss1 |
( |
( |
|
GAAP net loss per share – basic and diluted |
( |
( |
|
|
|
|
|
Non-GAAP net loss1,2 |
( |
( |
|
Non-GAAP net loss per share – basic and diluted1,2 |
( |
( |
- Information about
Velo3D's use of non-GAAP information, including a reconciliation to accounting principles generally accepted inthe United States of America ("GAAP"), is provided at the end of this release under "Non-GAAP Financial Information". The non-GAAP financial measures presented in this release should not be considered as the sole measure of the Company's performance and should not be considered in isolation from, or as a substitute for, comparable financial measures calculated in accordance with GAAP. - Non-GAAP net loss and non-GAAP net loss per basic and diluted share exclude stock-based compensation expense, loss on warrant cancellation, fair value adjustments for the Company's warrants and earnout liabilities, impairment of equipment subject to operating lease, and non-routine inventory adjustments for excess and obsolete inventory.
Summary of First Quarter 2026 Results
Total Revenue was
Gross margin for the first quarter was 17.2% compared to 7.5% in the first quarter of 2025. This change was primarily driven by the higher average selling price of Sapphire XC systems and increased RPS volume.
Operating expenses for the first quarter were
GAAP net loss for the first quarter was
As of
"On
Guidance
Management reiterates expectations for the full year 2026 to include:
- Revenue in the range of
$60 million to$70 million . - Sequential improvement in gross margin.
- Greater than 30% gross margin in second half of 2026.
- Non-GAAP adjusted operating expenses in the range of
$45 million to$55 million . - Capital expenditures in the range of
$40 million to$50 million , primarily for RPS expansion, subject to the availability of sufficient financing. - Positive EBITDA in the second half of 2026.
Conference Call
The Company will host a conference call for investors to discuss its first quarter 2026 financial results at
About
Amounts herein pertaining to the Company's first quarter ended
Forward-Looking Statements:
This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. The Company's actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect", "estimate", "project", "budget", "forecast", "anticipate", "intend", "plan", "may", "will", "could", "should", "believes", "predicts", "potential", "continue", and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company's guidance for fiscal year 2026 (including the Company's estimates for revenue, gross margin, operating expenses, and capital expenditures), the Company's expectations regarding its ability to achieve positive EBITDA in the second half of 2026, the Company's expectations about future demand, growth, profitability, long-term value, capacity requirements and operational efficiencies, scaled production, pipeline of opportunities, customer priorities, positive gross margins, the Company's expectations regarding its liquidity and capital requirements, including plans to raise additional capital to support its expansion and the potential sources and uses of that capital, the Company's expectations regarding its potential cost savings, the Company's expectations about its market strategy and financial and operational position, the Company's expectations that the RPS parts production business will contribute an increasing share of revenue, and the Company's other expectations, beliefs, intentions or strategies for the future. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. You should carefully consider the risks and uncertainties described in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Information
The information in the table below sets forth the non-GAAP financial measures that the Company uses in this release. Because of the inherent limitations associated with these non-GAAP financial measures, "Non-GAAP Net Loss", "Non-GAAP net loss per basic and diluted share", "EBITDA", "Adjusted EBITDA" and "Non-GAAP Adjusted Operating Expenses", should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. In addition, these non-GAAP financial measures may differ from, and should not be compared to, similarly named measures used by other companies. The Company compensates for these limitations by relying primarily on its GAAP results and using Non-GAAP Net Loss, Non-GAAP net loss per basic and diluted share, EBITDA, Adjusted EBITDA, and Non-GAAP Adjusted Operating Expenses on a supplemental basis. You should review the reconciliation of the non-GAAP financial measures below and not rely on any single financial measure to evaluate the Company's business.
Management believes adjusted "Non-GAAP Net Loss", "Non-GAAP net loss per basic and diluted share", "EBITDA", "Adjusted EBITDA" and "Non-GAAP Adjusted Operating Expenses" are useful to investors because they allow for comparison to the Company's performance in prior periods without the effect of items that, by their nature, tend to obscure the Company's core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. As a result, management believes that these measures enhance the ability of investors to analyze trends in the Company's business and evaluate the Company's performance relative to peer companies.
Reconciliations of the differences between these non-GAAP financial measures and their most directly comparable financial measures calculated in accordance with GAAP are set forth below.
The Company's non-GAAP adjusted operating expenses are calculated by excluding stock-based compensation recorded in operating expenses. The Company's non-GAAP EBITDA is calculated by excluding interest expense, provision (benefit) for income taxes, and depreciation and amortization. With respect to the Company's 2026 financial guidance regarding non-GAAP adjusted operating expenses and non-GAAP EBITDA, the Company cannot provide a quantitative reconciliation to the most directly comparable GAAP measure without unreasonable effort due to its inability to make accurate projections and estimates related to certain information needed to calculate some of the adjustments as described above.
|
Non-GAAP Net Loss Reconciliation (Unaudited)
|
|
|||||||||||||||||||||||
|
|
|
Three months ended |
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
($ In thousands) |
|
|||||||||||||||||||||
|
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|||||||||||||||
|
Revenue |
|
$ |
13,816 |
|
|
|
100.0 |
% |
|
$ |
9,441 |
|
|
|
100.0 |
% |
|
$ |
9,320 |
|
|
|
100.0 |
% |
|
Gross profit (loss) |
|
|
2,381 |
|
|
|
17.2 |
% |
|
|
(6,946) |
|
|
|
(73.6) |
% |
|
|
697 |
|
|
|
7.5 |
% |
|
Net Loss |
|
$ |
(6,998) |
|
|
|
(50.7) |
% |
|
$ |
(21,897) |
|
|
|
(231.9) |
% |
|
$ |
(25,014) |
|
|
|
(268.4) |
% |
|
Stock-based compensation |
|
|
1,889 |
|
|
|
13.7 |
% |
|
|
2,175 |
|
|
|
23.0 |
% |
|
|
3,596 |
|
|
|
38.6 |
% |
|
Loss on warrant cancellation |
|
|
— |
|
|
|
— |
% |
|
|
— |
|
|
|
— |
% |
|
|
11,357 |
|
|
|
121.9 |
% |
|
Loss on fair value of warrants |
|
|
— |
|
|
|
— |
% |
|
|
96 |
|
|
|
1.0 |
% |
|
|
1,044 |
|
|
|
11.2 |
% |
|
Impairment of equipment subject to operating lease |
|
|
— |
|
|
|
— |
% |
|
|
1,066 |
|
|
|
11.3 |
% |
|
|
— |
|
|
|
— |
% |
|
Gain on fair value of contingent earnout liabilities |
|
|
— |
|
|
|
— |
% |
|
|
(10) |
|
|
|
(0.1) |
% |
|
|
— |
|
|
|
— |
% |
|
Non-routine inventory adjustment for excess and obsolete inventory |
|
|
— |
|
|
|
— |
% |
|
|
6,979 |
|
|
|
73.9 |
% |
|
|
— |
|
|
|
— |
% |
|
Non-GAAP Net Loss |
|
$ |
(5,109) |
|
|
|
(37.0) |
% |
|
$ |
(11,591) |
|
|
|
(122.8) |
% |
|
$ |
(9,017) |
|
|
|
(96.7) |
% |
|
Non-GAAP Adjusted EBITDA Reconciliation (Unaudited)
|
||||||||||||||||||||||||
|
|
|
Three months ended |
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
($ In thousands) |
|
|||||||||||||||||||||
|
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|||||||||||||||
|
Revenue |
|
$ |
13,816 |
|
|
|
100.0 |
% |
|
$ |
9,441 |
|
|
|
100.0 |
% |
|
$ |
9,320 |
|
|
|
100.0 |
% |
|
Net Loss |
|
|
(6,998) |
|
|
|
(50.7) |
% |
|
|
(21,897) |
|
|
|
(231.9) |
% |
|
|
(25,014) |
|
|
|
(268.4) |
% |
|
Interest expense |
|
|
733 |
|
|
|
5.3 |
% |
|
|
524 |
|
|
|
5.6 |
% |
|
|
1,070 |
|
|
|
11.5 |
% |
|
Provision (benefit) for income taxes |
|
|
26 |
|
|
|
0.2 |
% |
|
|
34 |
|
|
|
0.4 |
% |
|
|
8 |
|
|
|
0.1 |
% |
|
Depreciation and amortization |
|
|
762 |
|
|
|
5.5 |
% |
|
|
1,026 |
|
|
|
10.9 |
% |
|
|
995 |
|
|
|
10.7 |
% |
|
EBITDA |
|
$ |
(5,477) |
|
|
|
(39.6) |
% |
|
$ |
(20,313) |
|
|
|
(215.2) |
% |
|
$ |
(22,941) |
|
|
|
(246.1) |
% |
|
Stock-based compensation |
|
|
1,889 |
|
|
|
13.7 |
% |
|
|
2,175 |
|
|
|
23.0 |
% |
|
|
3,596 |
|
|
|
38.6 |
% |
|
Loss on warrant cancellation |
|
|
— |
|
|
|
— |
% |
|
|
— |
|
|
|
— |
% |
|
|
11,357 |
|
|
|
121.9 |
% |
|
Loss on fair value of warrants |
|
|
— |
|
|
|
— |
% |
|
|
96 |
|
|
|
1.0 |
% |
|
|
1,044 |
|
|
|
11.2 |
% |
|
Impairment of equipment subject to operating lease |
|
|
— |
|
|
|
— |
% |
|
|
1,066 |
|
|
|
11.3 |
% |
|
|
— |
|
|
|
— |
% |
|
Gain on fair value of contingent earnout liabilities |
|
|
— |
|
|
|
— |
% |
|
|
(10) |
|
|
|
(0.1) |
% |
|
|
— |
|
|
|
— |
% |
|
Non-routine inventory adjustment for excess and obsolete inventory |
|
|
— |
|
|
|
— |
% |
|
|
6,979 |
|
|
|
73.9 |
% |
|
|
— |
|
|
|
— |
% |
|
Non-GAAP Adjusted EBITDA |
|
$ |
(3,588) |
|
|
|
(26.0) |
% |
|
$ |
(10,007) |
|
|
|
(106.0) |
% |
|
$ |
(6,944) |
|
|
|
(74.5) |
% |
|
Non-GAAP Adjusted Operating Expenses Reconciliation (Unaudited)
|
||||||||||||||||||||||||
|
|
|
Three months ended |
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
($ In thousands) |
|
|||||||||||||||||||||
|
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|||||||||||||||
|
Revenue |
|
$ |
13,816 |
|
|
|
100.0 |
% |
|
$ |
9,441 |
|
|
|
100.0 |
% |
|
$ |
9,320 |
|
|
|
100.0 |
% |
|
Operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Research and development |
|
|
2,695 |
|
|
|
19.5 |
% |
|
|
3,283 |
|
|
|
34.8 |
% |
|
|
2,059 |
|
|
|
22.1 |
% |
|
Selling and marketing |
|
|
1,721 |
|
|
|
12.5 |
% |
|
|
2,415 |
|
|
|
25.6 |
% |
|
|
1,086 |
|
|
|
11.7 |
% |
|
General and administrative |
|
|
4,912 |
|
|
|
35.6 |
% |
|
|
9,163 |
|
|
|
97.1 |
% |
|
|
9,076 |
|
|
|
97.4 |
% |
|
Total operating expenses |
|
$ |
9,328 |
|
|
|
67.5 |
% |
|
$ |
14,861 |
|
|
|
157.4 |
% |
|
$ |
12,221 |
|
|
|
131.1 |
% |
|
Stock-based compensation recorded in operating expenses |
|
|
1,246 |
|
|
|
9.0 |
% |
|
|
1,533 |
|
|
|
16.2 |
% |
|
|
3,387 |
|
|
|
36.3 |
% |
|
Non-GAAP Adjusted operating expenses |
|
$ |
8,082 |
|
|
|
58.5 |
% |
|
$ |
13,328 |
|
|
|
141.2 |
% |
|
$ |
8,834 |
|
|
|
94.8 |
% |
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (In thousands, except share and per share data)
|
||||||||
|
|
|
The three months ended |
|
|||||
|
|
|
2026 |
|
|
2025 |
|
||
|
Revenue |
|
|
|
|
|
|
||
|
3D Printer and parts |
|
$ |
12,021 |
|
|
$ |
7,523 |
|
|
Recurring payment |
|
|
— |
|
|
|
— |
|
|
Support services |
|
|
1,269 |
|
|
|
1,790 |
|
|
Other |
|
|
526 |
|
|
|
7 |
|
|
Total Revenue |
|
|
13,816 |
|
|
|
9,320 |
|
|
Cost of revenue |
|
|
|
|
|
|
||
|
3D Printer and parts |
|
|
10,225 |
|
|
|
7,540 |
|
|
Recurring payment |
|
|
— |
|
|
|
12 |
|
|
Support services |
|
|
1,210 |
|
|
|
1,071 |
|
|
Total cost of revenue |
|
|
11,435 |
|
|
|
8,623 |
|
|
Gross profit |
|
|
2,381 |
|
|
|
697 |
|
|
Operating expenses |
|
|
|
|
|
|
||
|
Research and development |
|
|
2,695 |
|
|
|
2,059 |
|
|
Selling and marketing |
|
|
1,721 |
|
|
|
1,086 |
|
|
General and administrative |
|
|
4,912 |
|
|
|
9,076 |
|
|
Total operating expenses |
|
|
9,328 |
|
|
|
12,221 |
|
|
Loss from operations |
|
|
(6,947) |
|
|
|
(11,524) |
|
|
Interest expense |
|
|
(733) |
|
|
|
(1,070) |
|
|
Loss on fair value of warrants |
|
|
— |
|
|
|
(1,044) |
|
|
Loss on warrant cancellation |
|
|
— |
|
|
|
(11,357) |
|
|
Other income (expense), net |
|
|
708 |
|
|
|
(11) |
|
|
Loss before income taxes |
|
|
(6,972) |
|
|
|
(25,006) |
|
|
Provision for income taxes |
|
|
(26) |
|
|
|
(8) |
|
|
Net loss |
|
$ |
(6,998) |
|
|
$ |
(25,014) |
|
|
|
|
|
|
|
|
|
||
|
Net loss per share: |
|
|
|
|
|
|
||
|
Basic and Diluted |
|
$ |
(0.28) |
|
|
$ |
(1.87) |
|
|
Shares used in computing net loss per share: |
|
|
|
|
|
|
||
|
Basic and Diluted |
|
|
25,021,065 |
|
|
|
13,398,104 |
|
|
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (In thousands, except share and per share data)
|
||||||||
|
|
|
|
|
|
|
|
||
|
|
|
2026 |
|
|
2025 |
|
||
|
Assets |
|
|
|
|
|
|
||
|
Current assets: |
|
|
|
|
|
|
||
|
Cash and cash equivalents |
|
$ |
16,564 |
|
|
$ |
39,013 |
|
|
Accounts receivable, net |
|
|
6,732 |
|
|
|
6,263 |
|
|
Inventories, net |
|
|
28,104 |
|
|
|
27,083 |
|
|
Contract assets |
|
|
4,120 |
|
|
|
2,039 |
|
|
Prepaid expenses and other current assets |
|
|
9,650 |
|
|
|
5,722 |
|
|
Total current assets |
|
|
65,170 |
|
|
|
80,120 |
|
|
Property and equipment, net |
|
|
16,387 |
|
|
|
13,094 |
|
|
Equipment subject to operating lease, net |
|
|
1,054 |
|
|
|
1,629 |
|
|
Other assets |
|
|
9,793 |
|
|
|
10,505 |
|
|
Total assets |
|
$ |
92,404 |
|
|
$ |
105,348 |
|
|
Liabilities and Stockholders' Equity |
|
|
|
|
|
|
||
|
Current liabilities: |
|
|
|
|
|
|
||
|
Accounts payable |
|
$ |
9,089 |
|
|
$ |
10,301 |
|
|
Accrued expenses and other current liabilities |
|
|
6,655 |
|
|
|
7,915 |
|
|
Debt – current portion |
|
|
3,135 |
|
|
|
6,305 |
|
|
Contract liabilities |
|
|
7,739 |
|
|
|
9,281 |
|
|
Total current liabilities |
|
|
26,618 |
|
|
|
33,802 |
|
|
Long-term debt – less current portion |
|
|
6,037 |
|
|
|
24,710 |
|
|
Contingent earnout liabilities |
|
|
1 |
|
|
|
1 |
|
|
Warrant liabilities |
|
|
109 |
|
|
|
109 |
|
|
Other noncurrent liabilities |
|
|
8,099 |
|
|
|
8,570 |
|
|
Total liabilities |
|
|
40,864 |
|
|
|
67,192 |
|
|
|
|
|
|
|
|
|
||
|
Stockholders' equity: |
|
|
|
|
|
|
||
|
Common stock, |
|
|
5 |
|
|
|
5 |
|
|
Additional paid-in capital |
|
|
556,676 |
|
|
|
536,294 |
|
|
Accumulated deficit |
|
|
(505,141) |
|
|
|
(498,143) |
|
|
Total stockholders' equity |
|
|
51,540 |
|
|
|
38,156 |
|
|
Total liabilities and stockholders' equity |
|
$ |
92,404 |
|
|
$ |
105,348 |
|
|
|
||||||||
|
|
|
The three months ended |
|
|||||
|
|
|
2026 |
|
|
2025 |
|
||
|
Cash flows from operating activities |
|
|
|
|
|
|
||
|
Net loss |
|
$ |
(6,998) |
|
|
$ |
(25,014) |
|
|
Adjustments to reconcile net loss to net cash used in operating activities |
|
|
|
|
|
|
||
|
Depreciation and amortization |
|
|
762 |
|
|
|
995 |
|
|
Amortization of debt discount and deferred financing costs |
|
|
17 |
|
|
|
48 |
|
|
Stock-based compensation |
|
|
1,889 |
|
|
|
3,596 |
|
|
Loss on fair value of warrants |
|
|
— |
|
|
|
1,044 |
|
|
Loss on warrant cancellation |
|
|
— |
|
|
|
11,357 |
|
|
Non-cash lease expense |
|
|
59 |
|
|
|
28 |
|
|
Changes in operating assets and liabilities |
|
|
|
|
|
|
||
|
Accounts receivable |
|
|
(469) |
|
|
|
(846) |
|
|
Inventories |
|
|
672 |
|
|
|
1,989 |
|
|
Contract assets |
|
|
(2,081) |
|
|
|
(795) |
|
|
Prepaid expenses and other current assets |
|
|
(3,928) |
|
|
|
(3,407) |
|
|
Other assets |
|
|
648 |
|
|
|
1,224 |
|
|
Accounts payable |
|
|
(5,504) |
|
|
|
(860) |
|
|
Accrued expenses and other liabilities |
|
|
(1,032) |
|
|
|
1,195 |
|
|
Contract liabilities |
|
|
(1,542) |
|
|
|
(2,671) |
|
|
Other noncurrent liabilities |
|
|
(471) |
|
|
|
(232) |
|
|
Net cash used in operating activities |
|
|
(17,978) |
|
|
|
(12,349) |
|
|
Cash flows from investing activities |
|
|
|
|
|
|
||
|
Purchase of property and equipment |
|
|
(940) |
|
|
|
— |
|
|
Net cash used in investing activities |
|
|
(940) |
|
|
|
— |
|
|
Cash flows from financing activities |
|
|
|
|
|
|
||
|
Proceeds from convertible secured notes |
|
|
— |
|
|
|
15,000 |
|
|
Repayment of 2025 equipment loan |
|
|
(496) |
|
|
|
— |
|
|
Repayment of secured notes |
|
|
(3,039) |
|
|
|
— |
|
|
Net cash (used in) provided by financing activities |
|
|
(3,535) |
|
|
|
15,000 |
|
|
Effect of exchange rate changes on cash and cash equivalents |
|
|
(1) |
|
|
|
7 |
|
|
Net change in cash and cash equivalents |
|
|
(22,454) |
|
|
|
2,658 |
|
|
Cash and cash equivalents and restricted cash at beginning of period |
|
|
39,641 |
|
|
|
1,840 |
|
|
Cash and cash equivalents and restricted cash at end of period |
|
$ |
17,187 |
|
|
$ |
4,498 |
|
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total of such amounts shown on the condensed consolidated statements of cash flows:
|
|
|
The three months ended |
|
|||||
|
|
|
2026 |
|
|
2025 |
|
||
|
Cash and cash equivalents |
|
$ |
16,564 |
|
|
$ |
3,870 |
|
|
Restricted cash (Other assets) |
|
|
623 |
|
|
|
628 |
|
|
Total cash and cash equivalents and restricted cash |
|
$ |
17,187 |
|
|
$ |
4,498 |
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/velo3d-announces-first-quarter-2026-financial-results-302770009.html
SOURCE